CR overview
| CR: | L3MBTL2 | |
| Accession: | Q969R5 | |
| Protein names: | Lethal(3)malignant brain tumor-like protein 2 | |
| Function type: | Histone Modifier | |
| Histone type: | Reader | |
| Methytor type: | Unkown | |
| Aliases: | RING2-L3MBTL2;MBT | |
| PMID: | 29581593 22770845 21596310 24369422 | |
| Disease: | 6 | |
| Go term: | 9 | |
| Pathway: | -- | |
| Hallmark: | -- | |
| Super Enhancer: |
|
|
| Enhancer: |
chr22:41214960-41215190 chr22:41543950-41545040 chr22:41562670-41564380 chr22:41620260-41620720 chr22:41620810-41620970 chr22:41621080-41621790 chr22:41687260-41689760 chr22:41565620-41566400 chr22:41681160-41681540 chr22:41613210-41615420 chr22:41756150-41758120 chr22:41318520-41320000 chr22:41404930-41406210 chr22:41430130-41431620 chr22:41591520-41593270 chr22:41612270-41613120 chr22:41622750-41623090 chr22:41918990-41919200 chr22:41919280-41919830 chr22:41919950-41920840 chr22:41920970-41921190 chr22:41926890-41928090 chr22:41621950-41622620 chr22:41925340-41926690 chr22:41403420-41404440 chr22:41523750-41525890 chr22:41856490-41858900 chr22:41997900-41999260 chr22:41745530-41747560 chr22:41632860-41633170 chr22:41721920-41723200 chr22:41763600-41766080 chr22:41876960-41879290 chr22:41921350-41921800 chr22:41729650-41732000 chr22:41703170-41705080 chr22:41737150-41738530 chr22:41870670-41873150 chr22:41873260-41874140 chr22:41874660-41876950 chr22:41928160-41928660 chr22:41347480-41349560 chr22:41526010-41527390 chr22:41560140-41562600 chr22:41913640-41914480 chr22:41914580-41916170 chr22:41531910-41533650 chr22:41222670-41223090 chr22:41223230-41224060 chr22:41457960-41458820 chr22:41443800-41446290 chr22:41701380-41702320 chr22:41789880-41790090 chr22:41805870-41808130 chr22:41960440-41962230 chr22:41907970-41910380 chr22:42008420-42010780 chr22:41502210-41503060 chr22:41904050-41905800 chr22:41634890-41635440 chr22:41676150-41676930 chr22:41556730-41558300 chr22:41397460-41398050 chr22:41398280-41399640 chr22:41576270-41578560 chr22:41747650-41748640 chr22:41543660-41543840 chr22:42000160-42002160 chr22:41305390-41306440 chr22:41307060-41308950 chr22:41564870-41565500 chr22:41582640-41583670 chr22:41838250-41838760 chr22:41911920-41913530 chr22:41893290-41895720 chr22:41680390-41680900 chr22:41625350-41625510 chr22:41631350-41632480 chr22:41610030-41612140 chr22:41625740-41626140 chr22:41716310-41716650 chr22:41716720-41717130 chr22:41627280-41628080 chr22:41825120-41826790 chr22:41899540-41901320 chr22:42342010-42342420 chr22:41827100-41829490 chr22:41811210-41812090 chr22:40704650-40706820 chr22:41618090-41620020 chr22:41642680-41643050 chr22:41714600-41715080 chr22:41723370-41724570 chr22:41739580-41741150 chr22:41911540-41911770 chr22:42076370-42078350 chr22:42078590-42080930 chr22:42196770-42199160 chr22:42229360-42231330 chr22:42297660-42298970 chr22:42299160-42300860 chr22:42300980-42301440 chr22:42335200-42336140 chr22:42341310-42341910 chr22:42354950-42357000 chr22:42359440-42360580 chr22:42373080-42374370 chr22:42475960-42477930 chr22:41204190-41206570 chr22:42303310-42305550 chr22:41144700-41145450 chr22:41566580-41568500 chr22:41439630-41440080 chr22:41833410-41835320 chr22:41721600-41721720 |
|
| Promoter: |
chr22:41203282-41207282 |
ChIP-seq based regulatory details of L3MBTL2
| Sample ID | CR | Biosample type | Biosample term name | File accession | Experiment accession | Source |
|---|---|---|---|---|---|---|
| CR_02_1299 | L3MBTL2 | cell line | K562 | SRR5111828 | GSE91847 | GEO |
| CR_02_1300 | L3MBTL2 | cell line | K562 | SRR5111829 | GSE91847 | GEO |
| CR_02_1306 | L3MBTL2 | cell line | HEK293T | SRR5112165 | GSE92109 | GEO |
| CR_02_1307 | L3MBTL2 | cell line | HEK293T | SRR5112166 | GSE92109 | GEO |
Downstream target genes of L3MBTL2
Upstream regulatory details of L3MBTL2
Protein-protein interaction of L3MBTL2
Annotation of L3MBTL2
TCGA cancer survival map of L3MBTL2
Other information of L3MBTL2